Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 123.11
+5.79 (4.94%)
At close: Jan 23, 2026
Bafna Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 87.72 | 41.53 | 73.48 | 113.38 | 52.16 | 58.27 | Upgrade |
Depreciation & Amortization | 47.13 | 48.9 | 49.95 | 53.34 | 54.93 | 44.78 | Upgrade |
Loss (Gain) From Sale of Assets | 0.74 | 0.74 | -0.66 | -1.96 | - | - | Upgrade |
Provision & Write-off of Bad Debts | -2.56 | -2.83 | 6 | 6.73 | - | - | Upgrade |
Other Operating Activities | 62.93 | 57.53 | 18.87 | 22.24 | -1.86 | -6.61 | Upgrade |
Change in Accounts Receivable | 10 | 55.04 | -48.46 | -270.42 | -61.12 | -35.25 | Upgrade |
Change in Inventory | -39.03 | 11.8 | -74.23 | -19.39 | -48.37 | -40.31 | Upgrade |
Change in Accounts Payable | 31.54 | -44.77 | 69.62 | 160.56 | 122.18 | -18.5 | Upgrade |
Change in Other Net Operating Assets | -42.8 | 53.42 | 0.28 | -14.95 | -20.64 | -138.48 | Upgrade |
Operating Cash Flow | 154.41 | 221.36 | 94.85 | 49.53 | 97.28 | -136.09 | Upgrade |
Operating Cash Flow Growth | 8.17% | 133.38% | 91.52% | -49.09% | - | - | Upgrade |
Capital Expenditures | -289.93 | -218.6 | -155.78 | -67.19 | -75.41 | -60.95 | Upgrade |
Sale of Property, Plant & Equipment | 15.1 | 0.59 | 1.71 | 1.96 | - | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | -2.7 | -15 | - | - | Upgrade |
Investment in Securities | -0.01 | -0.01 | - | - | - | - | Upgrade |
Other Investing Activities | 6.08 | 6.39 | 6.24 | 5.29 | 9.97 | 7.49 | Upgrade |
Investing Cash Flow | -268.76 | -211.63 | -150.54 | -74.93 | -65.44 | -53.45 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 98.68 | Upgrade |
Long-Term Debt Issued | - | 38.09 | 14.65 | 118.65 | - | 25 | Upgrade |
Total Debt Issued | 80.14 | 38.09 | 14.65 | 118.65 | - | 123.68 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | -47.27 | - | Upgrade |
Total Debt Repaid | 55.66 | - | - | - | -47.27 | - | Upgrade |
Net Debt Issued (Repaid) | 135.8 | 38.09 | 14.65 | 118.65 | -47.27 | 123.68 | Upgrade |
Other Financing Activities | -32.05 | -27.46 | -23.11 | -16.87 | -0.88 | -0.89 | Upgrade |
Financing Cash Flow | 103.75 | 10.64 | -8.45 | 101.77 | -48.15 | 122.8 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0.02 | Upgrade |
Net Cash Flow | -10.6 | 20.37 | -64.14 | 76.36 | -16.31 | -66.76 | Upgrade |
Free Cash Flow | -135.53 | 2.76 | -60.93 | -17.66 | 21.87 | -197.04 | Upgrade |
Free Cash Flow Margin | -9.52% | 0.19% | -4.00% | -1.53% | 2.57% | -27.67% | Upgrade |
Free Cash Flow Per Share | -5.73 | 0.12 | -2.58 | -0.75 | 0.93 | -8.32 | Upgrade |
Cash Interest Paid | 32.05 | 27.46 | 23.11 | 16.87 | 0.88 | 0.89 | Upgrade |
Cash Income Tax Paid | - | -3.5 | 1.74 | 1.28 | 1.7 | - | Upgrade |
Levered Free Cash Flow | -213.87 | -74.58 | -124.36 | -97.3 | 13.94 | -215.85 | Upgrade |
Unlevered Free Cash Flow | -194.76 | -58.57 | -112.25 | -86.07 | 17.22 | -215.29 | Upgrade |
Change in Working Capital | -40.3 | 75.49 | -52.8 | -144.2 | -7.95 | -232.53 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.